Literature DB >> 18474871

Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.

Krystian Jazdzewski1, Elizabeth L Murray, Kaarle Franssila, Barbara Jarzab, Daniel R Schoenberg, Albert de la Chapelle.   

Abstract

Although papillary thyroid carcinoma (PTC) displays strong heritability, no predisposing germ-line mutations have been found. We show that a common G/C polymorphism (rs2910164) within the pre-miR-146a sequence reduced the amount of pre- and mature miR-146a from the C allele 1.9- and 1.8-fold, respectively, compared with the G allele. This is matched by a similar decrease in the amount of each pre-miR generated from the corresponding pri-miR-146a in an in vitro processing reaction. The C allele also interfered with the binding of a nuclear factor to pre-miR-146a. The reduction in miR-146a led to less efficient inhibition of target genes involved in the Toll-like receptor and cytokine signaling pathway (TRAF6, IRAK1), and PTC1 (also known as CCDC6 or H4), a gene frequently rearranged with RET proto-oncogene in PTC. In an association study of 608 PTC patients and 901 controls, we found marked differences in genotype distribution of rs2910164 (P = 0.000002), the GC heterozygous state being associated with an increased risk of acquiring PTC (odds ratio = 1.62, P = 0.000007), and both homozygous states protective with odds ratio = 0.42 for the CC genotype (P = 0.003) and odds ratio = 0.69 for the GG genotype (P = 0.0006). Moreover, 4.7% of tumors had undergone somatic mutations of the SNP sequence. Thus, our data suggest that a common polymorphism in pre-miR-146a affects the miR expression, contributes to the genetic predisposition to PTC, and plays a role in the tumorigenesis through somatic mutation. Preliminary evidence suggests that these effects are mediated through target genes whose expression is affected by the SNP status.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474871      PMCID: PMC2438239          DOI: 10.1073/pnas.0802682105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Fast and effective prediction of microRNA/target duplexes.

Authors:  Marc Rehmsmeier; Peter Steffen; Matthias Hochsmann; Robert Giegerich
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

3.  Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.

Authors:  Jennifer E Cameron; Qinyan Yin; Claire Fewell; Michelle Lacey; Jane McBride; Xia Wang; Zhen Lin; Brian C Schaefer; Erik K Flemington
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

Authors:  I Bongarzone; M G Butti; S Coronelli; M G Borrello; M Santoro; P Mondellini; S Pilotti; A Fusco; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

6.  A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.

Authors:  F Canzian; P Amati; H R Harach; J L Kraimps; F Lesueur; J Barbier; P Levillain; G Romeo; D Bonneau
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

7.  Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.

Authors:  Francesco Pacifico; Claudio Mauro; Ciro Barone; Elvira Crescenzi; Stefano Mellone; Mario Monaco; Gennaro Chiappetta; Giuseppe Terrazzano; Domenico Liguoro; Pasquale Vito; Eduardo Consiglio; Silvestro Formisano; Antonio Leonardi
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

8.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

Authors:  R Visconti; J Cerutti; S Battista; M Fedele; F Trapasso; K Zeki; M P Miano; F de Nigris; L Casalino; F Curcio; M Santoro; A Fusco
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

9.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

Authors:  D E Goldgar; D F Easton; L A Cannon-Albright; M H Skolnick
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

10.  BRAF mutation in papillary thyroid carcinoma.

Authors:  Yoram Cohen; Mingzhao Xing; Elizabeth Mambo; Zhongmin Guo; Guogun Wu; Barry Trink; Uziel Beller; William H Westra; Paul W Ladenson; David Sidransky
Journal:  J Natl Cancer Inst       Date:  2003-04-16       Impact factor: 13.506

View more
  371 in total

1.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

2.  miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation.

Authors:  Ruozhen Hu; Dominique A Kagele; Thomas B Huffaker; Marah C Runtsch; Margaret Alexander; Jin Liu; Erin Bake; Wei Su; Matthew A Williams; Dinesh S Rao; Thomas Möller; Gwenn A Garden; June L Round; Ryan M O'Connell
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 3.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

4.  Discovery of common variants associated with low TSH levels and thyroid cancer risk.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Gisli Masson; Huiling He; Aslaug Jonasdottir; Asgeir Sigurdsson; Simon N Stacey; Hrefna Johannsdottir; Hafdis Th Helgadottir; Wei Li; Rebecca Nagy; Matthew D Ringel; Richard T Kloos; Marieke C H de Visser; Theo S Plantinga; Martin den Heijer; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; G Bragi Walters; Hjordis Bjarnason; Laufey Tryggvadottir; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Isleifur Olafsson; Kristleifur Kristjansson; Hoskuldur Kristvinsson; Olafur T Magnusson; Gudmar Thorleifsson; Jeffrey R Gulcher; Augustine Kong; Lambertus A L M Kiemeney; Thorvaldur Jonsson; Hannes Hjartarson; Jose I Mayordomo; Romana T Netea-Maier; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2012-01-22       Impact factor: 38.330

5.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

6.  Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies.

Authors:  Jun Wang; Jingwang Bi; Xin Liu; Kainan Li; Jianshi Di; Baocheng Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

7.  Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population.

Authors:  Ying Zeng; Qing-Min Sun; Nan-Nan Liu; Guang-Hui Dong; Jie Chen; Li Yang; Bin Wang
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

8.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

9.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

10.  Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population.

Authors:  Guo-Liang Huang; Mei-Ling Chen; Ya-Zhen Li; Yan Lu; Xing-Xiang Pu; Yu-Xiang He; Shu-Yin Tang; Hua Che; Ying Zou; Congcong Ding; Zhiwei He
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.